Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 13Withdrawn 2Terminated 2Unknown 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

UNKNOWN 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Glioblastoma 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × nabiximols × Clear all
NCT03246113 2019-08-13

Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

New York State Psychiatric Institute

Phase 1 Terminated
1 enrolled
CNS

Glioblastoma

NCT01975688 2016-08-11

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

GWPharm

Phase 1 Terminated
10 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡